---
title: "NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections"
ocid: "ocds-h6vhtk-049390"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-049390"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-049390.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-049390.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "WESTERN HEALTH AND SOCIAL CARE TRUST"
published: "2024-08-23"
---

# NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections

Buyer: WESTERN HEALTH AND SOCIAL CARE TRUST  
Current stage: Award  
OCID: ocds-h6vhtk-049390

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-049390)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-049390.json)

## Summary

The Western Health and Social Care Trust has completed a public procurement process for the supply of RIBOCICLIB (Kisqali) 200 mg tablets and SECUKINUMAB (Cosentyx) 150 mg in 1mL and 300 mg in 2mL injections. The procurement falls under the pharmaceutical products industry category and is located in the United Kingdom, specifically serving the Western Trust region in Londonderry. This tender, referenced as WT2024-11, WT2024-12, and WT2024-13, was awarded to Novartis Pharmaceuticals UK Limited on 16 August 2024. The contract for RIBOCICLIB will last until 15 August 2027, while the supply of SECUKINUMAB will continue until 3 August 2025. The procurement method used was a limited, negotiated procedure without prior publication, justifiable by the protection of exclusive rights as stipulated by Regulation 32(2)(b)iii.

This tender provides significant business growth opportunities, particularly for suppliers who deal with specialised pharmaceuticals covered by exclusive patents. Companies in the pharmaceutical sector, especially those able to navigate the regulations around intellectual property rights and exclusive distribution agreements, would find this type of contract highly beneficial. The Western Health and Social Care Trust's procurement ensures a consistent demand for these specialised treatments, potentially leading to long-term business relationships and stable revenue streams for qualified suppliers.

## Notice

Supply of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets to meet clinical need in the Western Trust until 15/08/2027. Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 03/08/2025.

### Lot Information

Lot 1

Supply of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets to meet clinical need in the Western Trust until 15/08/2027. Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 03/08/2025.

### Procurement Information

Regulation 32(2)(b)iii permits the award of a public contract by a negotiated procedure without prior publication where the works, supplies or services can only be supplied by a particular economic operator due to the protection of exclusive rights, including intellectual property rights. The absence of competition is not the result of an artificial narrowing down of the parameters of the procurement. The Western Health and Social Care Trust requires the purchase of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections which are subject to patent protection / Sole MA Holder and consequently no reasonable alternative of substitute exists.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/027072-2024 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 23 Aug 2024 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 15 Aug 2024 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1,532,303 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | WESTERN HEALTH AND SOCIAL CARE TRUST |
| Locality | Not specified |
| Post town | Not specified |
| Postcode | Not specified |
| Country | Not specified |
| ITL 1 | Not specified |
| ITL 2 | Not specified |
| ITL 3 | Not specified |
| Local authority | Not specified |
| Electoral ward | Not specified |
| Westminster constituency | Not specified |
| Delivery location | TLN Northern Ireland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | NOVARTIS PHARMACEUTICALS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 23 Aug 2024 at 12:01 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/027072-2024

## Notice URLs

- https://westerntrust.hscni.net/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-049390. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-049390.json.